CAPTA Reauthorization Act of 2021

Monitoring and outreach related to the following: -Additional funding for CAPTA programs in FY2023. -H.R.2617, Consolidated Appropriations Act, 2023. -H.R.8295 / S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023. -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act. -Child welfare and child abuse prevention, and primary prevention generally. -Implementation of Family First Prevention Services Act (FFPSA).

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Child welfare issues in general Implementation of the Family First Prevention Services Act -- included in PL 115-123; in general and specifically referring to the interaction between certain foster care placements and Medicaid law. Reauthorization of Title IV-B of the Social Security Act -- met with Congressional staff and relayed recommendations compiled by LACo Dept of Children and Family Services to Congressional offices Monitored the reauthorization of the Child Abuse Prevention and Treatment Act (CAPTA)-- Monitored the Senate Finance Committee Request for Information on Mental and Behavioral Health Monitored CMS guidance on Medicaid 1115 Waiver specifically serious mental illness/serious emotional disturbance (SMI/SED) and the implications for foster care groups home and interaction with the Institutions for Mental Disease exemption - advocated for legislation to address the issue. Researched and engaged Congressional staff on issues associated with the issuance of Social Security cards to children and youth in foster care. Advocated for an administrative resolution of the issue. Monitored action on the Maternal Infant and Early Childhood Home Visiting Program (MIECHV) Provided Congressional staff analysis and technical assistance on education stability and kinship navigation services Advocated in support of efforts to eliminate the AFDC income eligibility for foster care Bills -- HR 2611 - Increasing Behavioral Health Treatment Act S. 2689/HR 5414 Ensuring Medicaid Continuity for Children in Foster Care Act of 2021 HR 5856 -- 21st Century Children and Families Act HR 4299 - Foster Care Stabilization Act S. 1927/HR 485 CAPTA Reauthorization H.R. 8177 - Access to Foster Care to 21 Act H.R. 5856 -- Children's Safe Welcome Act of 2022 H.R. 8954 -- Strengthening Tribal Families Act of 2022 H.R. 8876 The Jackie Walorski Maternal and Child Home Visiting Reauthorization H.R. 9549 -- Fostering Secure Family Partnership Act Advocated on County child welfare priorities for inclusion in the end of year Omnibus spending bill -- P.L. 117-328

Client expense: Not reported · Firm income: $36,000

Government targets: Administration for Children & Families (ACF), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Reauthorization of the Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Program (H.R. 8876) Reauthorization of CAPTA (S. 1927/H.R. 485) Renew and enhance child tax credit Support robust funding for child sexual abuse prevention research

Client expense: Not reported · Firm income: Not reported

Reauthorization of the Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Program (H.R. 8876) Reauthorization of CAPTA (S. 1927/H.R. 485) Renew and enhance child tax credit Support robust funding for child sexual abuse prevention research

Client expense: Not reported · Firm income: Not reported

Reauthorization of the Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Program (H.R. 8876) Reauthorization of CAPTA (S. 1927/H.R. 485) Renew and enhance child tax credit Support robust funding for child sexual abuse prevention research

Client expense: Not reported · Firm income: Not reported

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Monitoring and outreach related to the following: -Child welfare and child abuse prevention, and primary prevention generally. -Implementation of Family First Prevention Services Act (FFPSA). -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Monitoring and outreach related to the following: -Additional funding for CAPTA programs in FY2023. -H.R.8295 / S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023. -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act. -Child welfare and child abuse prevention, and primary prevention generally. -Implementation of Family First Prevention Services Act (FFPSA).

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Monitoring and outreach related to the following: -Child welfare and child abuse prevention, and primary prevention generally. -Implementation of Family First Prevention Services Act (FFPSA). -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Monitoring and outreach related to the following: -Child welfare and child abuse prevention, and primary prevention generally. -Implementation of Family First Prevention Services Act (FFPSA). -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Maternal, Infant, and Early Childhood Home Visiting Reauthorization (HR 8876); Child Abuse Prevention and Treatment Act reauthorization (S 1927); Strengthening America's Families Act (HR 2973)to establish infant-toddler court programs to better address the needs of families with infants and toddlers in the child welfare system; potential reauthorization of Title IV-B of the Social Security Act (child welfare programs).

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Child welfare issues in general Implementation of the Family First Prevention Services Act -- included in PL 115-123; in general and specifically referring to the interaction between certain foster care placements and Medicaid law. Reauthorization of Title IV-B of the Social Security Act -- met with and relayed recommendations compiled by LACo Dept of Children and Family Services to Congressional offices Monitored the reauthorization of the Child Abuse Prevention and Treatment Act (CAPTA)-- Monitored the Senate Finance Committee Request for Information on Mental and Behavioral Health Monitored CMS guidance on Medicaid 1115 Waiver specifically serious mental illness/serious emotional disturbance (SMI/SED) and the implications for foster care groups home and interaction with the Institutions for Mental Disease exemption - advocated for legislation to address the issue. Researched and engaged Congressional staff on issues associated with the issuance of Social Security cards to children and youth in foster care. Advocated for an administrative resolution of the issue. Monitored action on the Maternal Infant and Early Childhood Home Visiting Program (MIECHV) Provided Congressional staff analysis and technical assistance on education stability and kinship navigation services Bills -- HR 2611 - Increasing Behavioral Health Treatment Act S. 2689/HR 5414 Ensuring Medicaid Continuity for Children in Foster Care Act of 2021 HR 5856 -- 21st Century Children and Families Act HR 4299 - Foster Care Stabilization Act S. 1927/HR 485 CAPTA Reauthorization H.R. 8177 - Access to Foster Care to 21 Act H.R. 5856 -- Children's Safe Welcome Act of 2022 H.R. 8954 -- Strengthening Tribal Families Act of 2022 H.R. 8876 The Jackie Walorski Maternal and Child Home Visiting Reauthorization

Client expense: Not reported · Firm income: $36,000

Government targets: Administration for Children & Families (ACF), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 2907/H.R. 5444 - Truth and Healing Commission on Indian Boarding School Policy Act S. 1275 - Family Violence Prevention and Services Improvement Act of 2021 S. 1927 - Child Abuse Prevention and Treatment Reauthorization Act of 2021 H.R. 3587 - Requirements, Expectations, and Standard Procedures for Executive Consultation with Tribes (RESPECT) Act S. Con. Res 28/H. Con. Res. 53 - September 30 Remembrance Day for the Native American children who died while attending a U.S. Indian boarding school

Client expense: $1,000,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1475/S.1795 Pursuing Equity in Mental Health Act S. 660/H.R. 2264: Tele-Mental Health Improvement Act H.R. 1364: Parity Enforcement Act S. 2086: The Resilience Investment, Support and Expansion (RISE) from Trauma Act S. 1927: Child Abuse Prevention and Treatment Act (CAPTA) Reauthorization of 2021 H.R 3467: Improving Data Collection for Adverse Childhood Experiences (ACEs) Act H.R. 1385: Behavioral Health Coordination and Communication Act S. 445: Mainstreaming Addiction Treatment Act S. 854: Methamphetamine Response Act S. 1457: STOP Fentanyl Act S. 1962/H.R. 3753: Parity Implementation Assistance Act Draft Global Enhancement of Mental Health and Psychosocial Support Access Act of 2021 H.R. 5218: Collaborate in an Orderly and Cohesive Manner Act S.2873 - Preventing and Addressing Trauma with Health Services (PATHS) Act Draft Reconciliation package Future Senate Finance Committee mental health legislation Future Cures 2.0 legislation from Rep. DeGette and Rep. Upton Draft Child Abuse and Neglect Data Collection and Improvement Act of 2021 Draft Legislation to award grants to 10 eligible crisis centers to provide follow-up services to individuals receiving suicide prevention and crisis intervention services (Rep. Trone) Coalition letter to state governors re: emergency temporary licensure waivers for out-of-state practitioners H.R. 5848 / S. 3149: Rural Health Equity Act Draft legislation to support reimbursement for psychology interns and residents in Medicare Draft legislation to support the reauthorization of Title VII programs H.R. 4026 Social Determinants of Health Data Analysis Act of 2021 H.R. 3894 CARING for Social Determinants Act of 2021 H.R. 3173 / S. 3018 Improving Seniors Access to Timely Care Act H.R. 7116 988 Implementation Act Draft bereavement care bill Letter to CDC re: Office of Rural Health Coalition thank-you letter to Congressional leadership and White House re: omnibus package S. 4301 Substance Use Prevention, Treatment, and Recovery Act S. 4306 Improving Access to Behavioral Health Integration Act S.4170 Mental Health Reform Reauthorization Act S.3824/H.R. 7073 Into the Light for MMH and SUD Act of 2022 H.R. 7666 Restoring Hope for Mental Health and Well-Being Act of 2022 H.R. 2955/ S. 4448 Suicide Prevention Act

Client expense: $260,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 1475/S.1795 Pursuing Equity in Mental Health Act S. 660/H.R. 2264: Tele-Mental Health Improvement Act H.R. 1364: Parity Enforcement Act S. 2086: The Resilience Investment, Support and Expansion (RISE) from Trauma Act S. 1927: Child Abuse Prevention and Treatment Act (CAPTA) Reauthorization of 2021 H.R 3467: Improving Data Collection for Adverse Childhood Experiences (ACEs) Act H.R. 1385: Behavioral Health Coordination and Communication Act S. 445: Mainstreaming Addiction Treatment Act S. 854: Methamphetamine Response Act S. 1457: STOP Fentanyl Act S. 1962/H.R. 3753: Parity Implementation Assistance Act Draft Global Enhancement of Mental Health and Psychosocial Support Access Act of 2021 H.R. 5218: Collaborate in an Orderly and Cohesive Manner Act S.2873 - Preventing and Addressing Trauma with Health Services (PATHS) Act Draft Reconciliation package Future Senate Finance Committee mental health legislation Future Cures 2.0 legislation from Rep. DeGette and Rep. Upton Draft Child Abuse and Neglect Data Collection and Improvement Act of 2021 Draft Legislation to award grants to 10 eligible crisis centers to provide follow-up services to individuals receiving suicide prevention and crisis intervention services (Rep. Trone) Coalition letter to state governors re: emergency temporary licensure waivers for out-of-state practitioners H.R. 5848 / S. 3149: Rural Health Equity Act Draft legislation to support reimbursement for psychology interns and residents in Medicare Draft legislation to support the reauthorization of Title VII programs H.R. 4026 Social Determinants of Health Data Analysis Act of 2021 H.R. 3894 CARING for Social Determinants Act of 2021 H.R. 3173 / S. 3018 Improving Seniors Access to Timely Care Act H.R. 7116 988 Implementation Act Draft bereavement care bill Letter to CDC re: Office of Rural Health Coalition thank-you letter to Congressional leadership and White House re: omnibus package S. 4301 Substance Use Prevention, Treatment, and Recovery Act S. 4306 Improving Access to Behavioral Health Integration Act S.4170 Mental Health Reform Reauthorization Act S.3824/H.R. 7073 Into the Light for MMH and SUD Act of 2022 H.R. 7666 Restoring Hope for Mental Health and Well-Being Act of 2022 H.R. 2955/ S. 4448 Suicide Prevention Act

Client expense: $260,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Child Abuse Prevention and Treatment Act reauthorization (S 1927); Strengthening America's Families Act (HR 2973)to establish infant-toddler court programs to better address the needs of families with infants and toddlers in the child welfare system; potential reauthorization of Title IV-B of the Social Security Act (child welfare programs).

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitoring and outreach related to the following: -Child welfare and child abuse prevention, and primary prevention generally. -Implementation of Family First Prevention Services Act (FFPSA). -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Monitoring and outreach related to the following: -Additional funding for CAPTA programs in FY2023. -H.R.8295 / Senate Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023. -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act. -Child welfare and child abuse prevention, and primary prevention generally. -Implementation of Family First Prevention Services Act (FFPSA).

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Monitoring and outreach related to the following: -Child welfare and child abuse prevention, and primary prevention generally. -Implementation of Family First Prevention Services Act (FFPSA). -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Monitoring and outreach related to the following: -Child welfare and child abuse prevention, and primary prevention generally. -Implementation of Family First Prevention Services Act (FFPSA). -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Child welfare issues in general Implementation of the Family First Prevention Services Act -- included in PL 115-123; in general and specifically referring to the interaction between certain foster care placements and Medicaid law. Reauthorization of Title IV-B of the Social Security Act -- relayed recommendations compiled by LACo Dept of Children and Family Services to Congressional offices Monitored the reauthorization of the Child Abuse Prevention and Treatment Act (CAPTA)-- Monitored the Senate Finance Committee Request for Information on Mental and Behavioral Health Monitored CMS guidance on Medicaid 1115 Waiver specifically serious mental illness/serious emotional disturbance (SMI/SED) and the implications for foster care groups home and interaction with the Institutions for Mental Disease exemption Researched and engaged Congressional staff on issues associated with the issuance of Social Security cards to children and youth in foster care. Bills -- HR 2611 - Increasing Behavioral Health Treatment Act S. 2689/HR 5414 Ensuring Medicaid Continuity for Children in Foster Care Act of 2021 HR 1658 - To Amend the Child Abuse Prevention and Treatment Act to promote a high-quality workforce in the child welfare system HR 5856 -- 21st Century Children and Families Act S. 503 PARENTS Act of 2021 HR 4299 - Foster Care Stabilization Act S. 1927/HR 485 CAPTA Reauthorization H.R. 8177 - Access to Foster Care to 21 Act

Client expense: Not reported · Firm income: $36,000

Government targets: Administration for Children & Families (ACF), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 2907/H.R. 5444 - Truth and Healing Commission on Indian Boarding School Policy Act S. 1275 - Family Violence Prevention and Services Improvement Act of 2021 S. 1927 - Child Abuse Prevention and Treatment Reauthorization Act of 2021 H.R. 3587 - Requirements, Expectations, and Standard Procedures for Executive Consultation with Tribes (RESPECT) Act H.R. 6707 - Advancing Equality for Wabanaki Nations Act

Client expense: $1,000,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1475/S.1795 Pursuing Equity in Mental Health Act S. 660/H.R. 2264: Tele-Mental Health Improvement Act H.R. 1364: Parity Enforcement Act S. 2086: The Resilience Investment, Support and Expansion (RISE) from Trauma Act S. 1927: Child Abuse Prevention and Treatment Act (CAPTA) Reauthorization of 2021 H.R 3467: Improving Data Collection for Adverse Childhood Experiences (ACEs) Act H.R. 1385: Behavioral Health Coordination and Communication Act S. 445: Mainstreaming Addiction Treatment Act S. 854: Methamphetamine Response Act S. 1457: STOP Fentanyl Act S. 1962/H.R. 3753: Parity Implementation Assistance Act Draft Global Enhancement of Mental Health and Psychosocial Support Access Act of 2021 H.R. 5218: Collaborate in an Orderly and Cohesive Manner Act S.2873 - Preventing and Addressing Trauma with Health Services (PATHS) Act Draft Reconciliation package Future Senate Finance Committee mental health legislation Future Cures 2.0 legislation from Rep. DeGette and Rep. Upton Draft Child Abuse and Neglect Data Collection and Improvement Act of 2021 Draft Legislation to award grants to 10 eligible crisis centers to provide follow-up services to individuals receiving suicide prevention and crisis intervention services (Rep. Trone) Coalition letter to state governors re: emergency temporary licensure waivers for out-of-state practitioners H.R. 5848 / S. 3149: Rural Health Equity Act Draft legislation to support reimbursement for psychology interns and residents in Medicare Draft legislation to support the reauthorization of Title VII programs H.R. 4026 Social Determinants of Health Data Analysis Act of 2021 H.R. 3894 CARING for Social Determinants Act of 2021 H.R. 3173 / S. 3018 Improving Seniors Access to Timely Care Act H.R. 7116 988 Implementation Act Draft bereavement care bill Letter to CDC re: Office of Rural Health Coalition thank-you letter to Congressional leadership and White House re: omnibus package S. 4301 Substance Use Prevention, Treatment, and Recovery Act S. 4306 Improving Access to Behavioral Health Integration Act S.4170 Mental Health Reform Reauthorization Act S.3824/H.R. 7073 Into the Light for MMH and SUD Act of 2022 H.R. 7666 Restoring Hope for Mental Health and Well-Being Act of 2022 H.R. 2955/ S. 4448 Suicide Prevention Act

Client expense: $260,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office

S. 1927, Child Abuse Prevention and Treatment Act (CAPTA) Reauthorization Act-provisions that ensure children and parents are represented by a trained attorney in all cases involving an allegation of child abuse or neglect that results in a judicial proceeding.

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Paid family and medical leave (FAMILY Act (H.R. 805, S. 248)and Build Back Better Act (H.R. 5376) to promote paid leave for families to bond with their children and care for themselves or family members; Child Abuse Prevention and Treatment Act reauthorization (S 1927); Strengthening America's Families Act (HR 2973)to establish infant-toddler court programs to better address the needs of families with infants and toddlers in the child welfare system.

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 3623 - Violence Against Women Reauthorization Act of 2022 S. 1275 - Family Violence Prevention and Services Improvement Act of 2021 S. 1927 - Child Abuse Prevention and Treatment Reauthorization Act of 2021 S. 2907/H.R. 5444 - Truth and Healing Commission on Indian Boarding School Policy Act

Client expense: $1,000,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Child welfare issues in general Implementation of the Family First Prevention Services Act -- included in PL 115-123; in general and specifically referring to the interaction between certain foster care placements and Medicaid law. Reauthorization of Title IV-B of the Social Security Act HR 2611 - Increasing Behavioral Health Treatment Act S. 2689/HR 5414 Ensuring Medicaid Continuity for Children in Foster Care Act of 2021 HR 5661/S. 3078 - Continued State Flexibility to Assist Older Foster Youth Act HR 1658 - To Amend the Child Abuse Prevention and Treatment Act to promote a high-quality workforce in the child welfare system S. 1496 Child Welfare Workforce Support Act HR 1558 - Child Poverty Reduction Act of 2021 S. 2638 - Family Strengthening Infrastructure Act HR 5856 -- 21st Century Children and Families Act S. 503 PARENTS Act of 2021 HR 4299 - Foster Care Stabilization Act S. 1927/HR 485 CAPTA Reauthorization S. 1848/HR 3488 - John Lewis Every Child Deserves a Family Act HR 3083 - Foster Youth Mentor Act Monitored the reauthorization of the Child Abuse Prevention and Treatment Act (CAPTA)-- Monitored the Senate Finance Committee Request for Information on Mental and Behavioral Health Monitored CMS guidance on Medicaid 1115 Waiver specifically serious mental illness/serious emotional disturbance (SMI/SED) and the implications for foster care groups home and interaction with the Institutions for Mental Disease exemption Also monitored the release of the President's FY 2023 Budget

Client expense: Not reported · Firm income: $36,000

Government targets: Administration for Children & Families (ACF), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1475/S. 1795 Pursuing Equity in Mental Health Act S. 660/H.R. 2264: Tele-Mental Health Improvement Act H.R. 1364: Parity Enforcement Act S. 2086: The Resilience Investment, Support and Expansion (RISE) from Trauma Act S. 1927: Child Abuse Prevention and Treatment Act (CAPTA) Reauthorization of 2021 H.R 3467: Improving Data Collection for Adverse Childhood Experiences (ACEs) Act H.R. 1385: Behavioral Health Coordination and Communication Act S. 445: Mainstreaming Addiction Treatment Act S. 854: Methamphetamine Response Act S. 1457: STOP Fentanyl Act S. 1962/H.R. 3753: Parity Implementation Assistance Act Draft Global Enhancement of Mental Health and Psychosocial Support Access Act of 2021 Draft integrated care legislation H.R. 5218: Collaborate in an Orderly and Cohesive Manner Act Draft PrEP Assistance Program Act S.2873 - Preventing and Addressing Trauma with Health Services (PATHS) Act Draft Reconciliation package Future Senate Finance Committee mental health legislation Future Cures 2.0 legislation from Rep. DeGette and Rep. Upton Draft Child Abuse and Neglect Data Collection and Improvement Act of 2021 Draft Legislation to award grants to 10 eligible crisis centers to provide follow-up services to individuals receiving suicide prevention and crisis intervention services (Rep. Trone) Coalition letter to state governors re: emergency temporary licensure waivers for out-of-state practitioners H.R. 5848 / S. 3149: Rural Health Equity Act Draft legislation to support reimbursement for psychology interns and residents in Medicare Draft legislation to support the reauthorization of Title VII programs H.R. 4026 Social Determinants of Health Data Analysis Act of 2021 H.R. 3894 CARING for Social Determinants Act of 2021 H.R. 3173 / S. 3018 Improving Seniors Access to Timely Care Act H.R. 7116 988 Implementation Act

Client expense: $226,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitoring and outreach related to the following: -Child welfare and child abuse prevention, and primary prevention generally. -H.R. 485, Stronger Child Abuse Prevention and Treatment Act. -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Monitoring and outreach related to the following: -Child welfare and child abuse prevention, and primary prevention generally. -H.R. 485, Stronger Child Abuse Prevention and Treatment Act. -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Monitoring and outreach related to the following: -Child welfare and child abuse prevention, and primary prevention generally. -H.R. 485, Stronger Child Abuse Prevention and Treatment Act. -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Monitoring and outreach related to the following: -Additional funding for CAPTA programs in FY2022. -H.R.4502 Consolidated Appropriations, Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022. -S. 3062, Labor, Health and Human Services Appropriations, FY2022. -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act. -Child welfare and child abuse prevention, and primary prevention generally. -H.R. 485, Stronger Child Abuse Prevention and Treatment Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Paid family and medical leave (FAMILY Act (H.R. 805, S. 248)and Build Back Better Act (H.R. 5376) to promote paid leave for families to bond with their children and care for themselves or family members; Child Abuse Prevention and Treatment Act reauthorization (S 1927); Strengthening America's Families Act (HR 2973)to establish infant-toddler court programs to better address the needs of families with infants and toddlers in the child welfare system.

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The Cardenas HEART (Health Equity Access, Resources, and Treatment) Package H.R. 2295 - HIV Epidemic Loan-Repayment (HELP) Act of 2021 S.1927 - CAPTA Reauthorization Act of 2021 H.R.3862/S.2046 - Community-Based Response Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

H.R. 1475/S. 1795 Pursuing Equity in Mental Health Act S. 660/H.R. 2264: Tele-Mental Health Improvement Act H.R. 1364: Parity Enforcement Act S. 2086: The Resilience Investment, Support and Expansion (RISE) from Trauma Act S. 1927: Child Abuse Prevention and Treatment Act (CAPTA) Reauthorization of 2021 H.R 3467: Improving Data Collection for Adverse Childhood Experiences (ACEs) Act H.R. 4305: Crisis Care Enhancement Act H.R. 1385: Behavioral Health Coordination and Communication Act H.R. 5182: COCM Act S. 445: Mainstreaming Addiction Treatment Act S. 854: Methamphetamine Response Act S. 1457: STOP Fentanyl Act S. 1962/H.R. 3753: Parity Implementation Assistance Act Draft Global Enhancement of Mental Health and Psychosocial Support Access Act of 2021 Draft integrated care legislation H.R. 5218: Collaborate in an Orderly and Cohesive Manner Act Draft PrEP Assistance Program Act S.2873 - Preventing and Addressing Trauma with Health Services (PATHS) Act Draft Reconciliation package Future Senate Finance Committee mental health legislation Future Cures 2.0 legislation from Rep. DeGette and Rep. Upton Draft Child Abuse and Neglect Data Collection and Improvement Act of 2021 Draft Legislation to award grants to 10 eligible crisis centers to provide follow-up services to individuals receiving suicide prevention and crisis intervention services (Rep. Trone) Coalition letter to state governors re: emergency temporary licensure waivers for out-of-state practitioners H.R. 5848 / S. 3149: Rural Health Equity Act

Client expense: $300,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Justice, Dept of (DOJ), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office

Legislation and policies relating to: Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Reauthorization of the Childrens Health Insurance Program Reauthorization of the Child Nutrition Act Section 2706 of the ACA regarding provider non-discrimination Policies affecting nurse practitioner education and workforce Definition, evaluation and enforcement of essential health benefits and provider network adequacy Health information technology and electronic health records Mental health services and violence prevention Provisions of the Infrastructure Investment and Jobs Act (H.R. 3684) related to public health infrastructure improvements Provisions of the draft Build Back Better Act related to health equity, social determinants of health, mental and behavioral health for patients and health care providers, and child and maternal health H.R. 66, Comprehensive Access to Robust Insurance Now Guaranteed for Kids (CARING for Kids) Act H.R. 482, Newborn Screening Saves Lives Reauthorization Act of 2021 H.R. 485, Stronger Child Abuse Prevention and Treatment Act H.R. 909/S. 484, Moms Matter Act H.R. 959/S. 346, Black Maternal Health Momnibus Act of 2021 H.R. 1065/S. 1486, Pregnant Workers Fairness Act H.R. 1324/S/ 467, Effective Suicide Screening and Assessment in the Emergency Department Act of 2021 H.R. 1390, Childrens Health Insurance Program Pandemic Enhancement and Relief (CHIPPER) Act H.R. 1791, Childrens Health Insurance Program Permanency (CHIPP) Act H.R. 2094/S. 1301, Promoting Physical Activity for Americans Act H.R. 2347/S. 2691, Strengthening the Vaccines for Children Program Act of 2021 H.R. 3182, Safe Sleep for Babies Act of 2021 H.R. 4217, Taskforce Recommending Improvements for Unaddressed Mental Perinatal & Postpartum Health (TRIUMPH) for New Moms Act S. 104/H.R. 379, Improving Social Determinants of Health Act of 2021 S. 248/H.R. 804, Family and Medical Insurance Leave (FAMILY) Act S. 499/H.R. 369, Improving Health Insurance Affordability Act of 2021 S. 610/H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act S. 674, Public Health Infrastructure Saves Lives Act S. 844/H.R. 3109, PHIT Act of 2021 S. 987, Comprehensive Addiction and Recovery Act (CARA) 3.0 S. 1259, Safe Cribs Act S. 1275/H.R. 2119, Family Violence Prevention and Services Improvement Act of 2021 S. 1301/H.R. 2094, Promoting Physical Activity for Americans Act S. 1658/H.R. 3110, Providing Urgent Maternal Protections for Nursing Mothers Act S. 1675, Maternal Health Quality Improvement Act S. 1902, Behavioral Health Crisis Services Expansion Act S. 1927, the Child Abuse Prevention and Treatment Act (CAPTA) Reauthorization Act of 2021

Client expense: Not reported · Firm income: $24,000

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)

Paid family and medical leave (FAMILY Act (H.R. 805, S. 248) to promote paid leave for families to bond with their children and care for themselves or family members; Child Abuse Prevention and Treatment Act reauthorization (S 1927); Strengthening America's Families Act (HR 2973)to establish infant-toddler court programs to better address the needs of families with infants and toddlers in the child welfare system.

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitoring and outreach related to the following: -Child welfare and child abuse prevention, and primary prevention generally. -H.R. 485, Stronger Child Abuse Prevention and Treatment Act. -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act.

Client expense: Not reported · Firm income: Not reported

Government targets: Health & Human Services, Dept of (HHS)

Monitoring and outreach related to the following: -Additional funding for CAPTA programs in FY2022. -H.R.4502 Consolidated Appropriations, Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022. -Senate Draft, Labor, Health and Human Services Appropriations, FY2022. -S. 1927, CAPTA Reauthorization Act of 2021. -Reauthorization of Title IV-B of the Social Security Act. -Child welfare and child abuse prevention, and primary prevention generally. -H.R. 485, Stronger Child Abuse Prevention and Treatment Act.

Client expense: Not reported · Firm income: Not reported

Government targets: Health & Human Services, Dept of (HHS)